A newly identified biomarker could help scientists pinpoint which cancers are vulnerable to treatment with biguanides, a common class of medications used to control blood sugar in Type 2 diabetes.
from Medindia Health News https://ift.tt/2yhMyTi
No comments:
Post a Comment